Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

In vitro and in vivo effects of an alpha3 neuronal nicotinic acetylcholine receptor antisense oligonucleotide.

Adams MR, Nikkel AL, Donnelly-Roberts DL, Watt AT, Johnston JF, Cowsert LM, Butler M, Kroeger PE, Frost L, Curzon P, Decker MW, Bitner RS.

Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):67-79.

PMID:
15469883
2.

Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.

Cavarretta IT, Mukopadhyay R, Lonard DM, Cowsert LM, Bennett CF, O'Malley BW, Smith CL.

Mol Endocrinol. 2002 Feb;16(2):253-70.

PMID:
11818499
3.

Application of antisense oligonucleotides for gene functionalization and target validation.

Bennett CF, Cowsert LM.

Curr Opin Mol Ther. 1999 Jun;1(3):359-71. Review.

PMID:
11713801
4.

Web alert. Antisense--from design to clinic.

Cowsert LM.

Curr Opin Mol Ther. 2000 Jun;2(3):235. No abstract available.

PMID:
11249616
5.

5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.

Taylor V, Wong M, Brandts C, Reilly L, Dean NM, Cowsert LM, Moodie S, Stokoe D.

Mol Cell Biol. 2000 Sep;20(18):6860-71.

6.

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth.

Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC, Ng SC.

Neoplasia. 2000 May-Jun;2(3):235-41.

7.

Antisense oligonucleotides as a tool for gene functionalization and target validation.

Bennett CF, Cowsert LM.

Biochim Biophys Acta. 1999 Dec 10;1489(1):19-30. Review. No abstract available.

PMID:
10806994
8.

MMI linkage modification increases potency and stability of H-ras antisense oligonucleotides.

Cowsert LM, Ohashi CT, Bhat B, Peoc'h D, Symons AM, Cook PD, Manoharan M.

Nucleosides Nucleotides. 1999 Jun-Jul;18(6-7):1383-4. No abstract available.

PMID:
10474224
9.

Evidence of a role for Ki-Ras in the stimulated proliferation of renal fibroblasts.

Sharpe CC, Dockrell ME, Scott R, Noor MI, Cowsert LM, Monia BP, Hendry BM.

J Am Soc Nephrol. 1999 Jun;10(6):1186-92.

10.
11.

A novel drug screening assay for papillomavirus specific antiviral activity.

Clark PR, Roberts ML, Cowsert LM.

Antiviral Res. 1998 Feb;37(2):97-106.

PMID:
9588842
12.

In vitro and in vivo activity of antisense inhibitors of ras: potential for clinical development.

Cowsert LM.

Anticancer Drug Des. 1997 Jul;12(5):359-71. Review. No abstract available.

PMID:
9236852
15.

Treatment of papillomavirus infections: recent practice and future approaches.

Cowsert LM.

Intervirology. 1994;37(3-4):226-30. Review. No abstract available.

PMID:
7843933
16.
17.
18.

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction.

Baker TS, Newcomb WW, Olson NH, Cowsert LM, Olson C, Brown JC.

Biophys J. 1991 Dec;60(6):1445-56.

19.

Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.

Jin XW, Cowsert LM, Pilacinski WP, Jenson AB.

J Gen Virol. 1989 May;70 ( Pt 5):1133-40.

PMID:
2471804
20.

Identification of the bovine papillomavirus L1 gene product using monoclonal antibodies.

Cowsert LM, Pilacinski WP, Jenson AB.

Virology. 1988 Aug;165(2):613-5.

PMID:
2841806
21.

Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies.

Cowsert LM, Lake P, Jenson AB.

J Natl Cancer Inst. 1987 Nov;79(5):1053-7.

PMID:
2446044

Supplemental Content

Loading ...
Support Center